A randomized, parallel-group, multicenter clinical trial to evaluate the preventive effect on acute exacerbation of chronic obstructive pulmonary disease (COPD) with Carbocisteine (1500mg/day)

Authors
Category Primary study
JournalUMIN Clinical Trials Registry
Year 2006
INTERVENTION: Carbocisteine treatment group 1500mg/day (13 months) Treatment group without mucolytic agents including Carbocisteine (13 months) CONDITION: COPD PRIMARY OUTCOME: Frequency of exacerbations INCLUSION CRITERIA: 1. Stable COPD patient (Stage II‐IV) 2. Between 40 and 80 years 3. Out‐patient 4. Written informed consent 5. At least 2 exacerbations in the previous 2 years
Epistemonikos ID: 21ffcfd5acd80d4d66d1e54a9e23422e51384593
First added on: Aug 21, 2024